Flagship Pioneering, which for more than 25 years has created and nurtured startupsāmost notably mRNA vaccine giant Modernaāfrom Cambridge, MA, has launched its first dedicated company creation unit outside of the U.S. with an initial commitment of Ā£100 million ($131.66 million) that the venture capital giant expects to quintuple in coming years.
The new London-based Flagship Origination Lab U.K. has been established to conceive, test, fund, and build artificial intelligence (AI)-native platform companies that advance human and planetary health and other frontiers of science and technology.
Flagship said the U.K. Lab will operate as part of Flagship Labs, the companyās innovation foundry, with the goal of creating a locally rooted company-creation ecosystem in the United Kingdom that connects to Flagshipās broader global ecosystem, including business units and:
- Pioneering Intelligence, Flagshipās AI and machine learning innovation effort designed to originate new companies by harnessing advances in computation integrated with…
Click here to view original postClick Here to Publish/Feature Your Company or Product News with Biotech Networks

